uuid,file_name,file_timestamp,file_date,file_duplicate,file_md5,file_size,file_url
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-20_23-19.html,1663730340,2022-09-20,0,0e12c82f0b86b7bb79b04564bf1b1f45,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-20_23-19.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-21_22-08.html,1663812480,2022-09-21,0,ee1c2898257dc38bbe2ffe03f531f070,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-21_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-22_22-08.html,1663898880,2022-09-22,0,d537485306fee7c945782bf640aaef13,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-22_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-23_22-09.html,1663985340,2022-09-23,0,d1a5f95c017156da541e4837e86cc791,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-23_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-24_22-09.html,1664071740,2022-09-24,0,2c8a30c02e49d7356a72da27ac45ab4d,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-24_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-25_22-08.html,1664158080,2022-09-25,0,66b0e9c79dfa405b4530ccb8a77066e3,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-25_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-26_22-08.html,1664244480,2022-09-26,0,1c2083d6adadfe0010f5e6b265968d6c,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-26_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-27_22-09.html,1664330940,2022-09-27,0,d3edf9d70cb3feab010168b60462f27a,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-27_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-28_22-09.html,1664417340,2022-09-28,0,4b9378f678943f6d4ac8a7b1bd4a9c01,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-28_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-29_22-09.html,1664503740,2022-09-29,0,bd685822012c6ff846a406b5d1b0ec0c,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-29_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-30_22-09.html,1664590140,2022-09-30,0,2e46181c941b57758c86d999ac109183,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-09-30_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-01_22-08.html,1664676480,2022-10-01,0,c083c4f07dccf2183f6bf46300a403d3,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-01_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-02_22-09.html,1664762940,2022-10-02,0,1d4b494b86c5f3ed03f750fab3498737,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-02_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-03_22-09.html,1664849340,2022-10-03,0,f5a73de2739131c583bfa40bc8f5eabb,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-03_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-04_22-08.html,1664935680,2022-10-04,0,1ee3ab0c481d00236e1dbe750ecedfed,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-04_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-05_22-09.html,1665022140,2022-10-05,0,4cd2cb14964c046c6cbbf9988154e058,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-05_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-06_22-09.html,1665108540,2022-10-06,0,e301b642cc725d19967448bb4d1cd507,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-06_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-07_22-08.html,1665194880,2022-10-07,0,d6e34e3594c5e84f7be580a871b094b7,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-07_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-08_22-08.html,1665281280,2022-10-08,0,09c5a199fe54ccbdb5945d2457b16c98,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-08_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-09_22-08.html,1665367680,2022-10-09,0,86276c25acbfce632083b8ea63bb803e,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-09_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-10_22-09.html,1665454140,2022-10-10,0,e362b925997631ce895a0bf2f778e9e2,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-10_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-11_22-09.html,1665540540,2022-10-11,0,74828e7a51691c8cf2de895e5022586a,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-11_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-12_22-09.html,1665626940,2022-10-12,0,ea26b781c0b81178aedeb9c6a35159fd,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-12_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-13_22-08.html,1665713280,2022-10-13,0,b38501922fa006af9fc2b332349120e5,277574,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-13_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-14_22-08.html,1665799680,2022-10-14,0,f442c9022ca7c186a7fc69a2425ac199,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-14_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-15_22-09.html,1665886140,2022-10-15,0,46d3c2039edcee64c60d2d1365c73cf0,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-15_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-16_22-09.html,1665972540,2022-10-16,0,49d84e06fcfc857f9955e84ca6538789,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-16_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-17_22-09.html,1666058940,2022-10-17,0,9182e3da0ff4ffa7e2a813043c603942,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-17_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-18_22-08.html,1666145280,2022-10-18,0,e17a3672279ca0fffc988d797458ff7f,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-18_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-19_22-09.html,1666231740,2022-10-19,0,b417feccf3064e7983792b524770aa09,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-19_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-20_22-08.html,1666318080,2022-10-20,0,38097267d0eb065fe7680fb07ae8665b,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-20_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-21_22-08.html,1666404480,2022-10-21,0,0426f471da6bd16dc5d01ad9bd4bf28f,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-21_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-22_22-09.html,1666490940,2022-10-22,0,668800df3b41ac170e9d205c7210a74b,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-22_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-23_22-08.html,1666577280,2022-10-23,0,ea845523f08d3fcb67d58a45192d6bd8,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-23_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-24_22-08.html,1666663680,2022-10-24,0,4ad8f5f08a0edc4fec9d7895d42d2f17,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-24_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-25_22-09.html,1666750140,2022-10-25,0,e721d91de931e6cdd68aac8a2d45c5a5,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-25_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-26_22-08.html,1666836480,2022-10-26,0,021969f2ca86a4ac040e837b9b021761,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-26_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-27_22-09.html,1666922940,2022-10-27,0,a8d4915c68c65170b5df6e7361cd46d4,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-27_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-28_22-08.html,1667009280,2022-10-28,0,ea49639ad6c09c6d20c7796c481cac2c,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-28_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-29_22-08.html,1667095680,2022-10-29,0,58c4292a7461ac74ca4d906cbedf1aaf,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-29_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-30_22-09.html,1667182140,2022-10-30,0,2d68b66b36c2dc31d606b47c878a8820,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-30_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-31_22-38.html,1667270280,2022-10-31,0,3525e97a9901fd3f71b3608940bfd01e,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-10-31_22-38.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-01_22-08.html,1667354880,2022-11-01,0,208352435ee9da289547f17f1900648a,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-01_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-02_22-09.html,1667441340,2022-11-02,0,c3991c051150fc2f63e288c9b5a4e19d,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-02_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-03_22-08.html,1667527680,2022-11-03,0,04cf7f2261d57c7c8d7cb4ba5ed9f5ee,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-03_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-04_22-09.html,1667614140,2022-11-04,0,5901ed63e239683264bf7f64537784eb,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-04_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-05_22-09.html,1667700540,2022-11-05,0,e6261216eb015627e10f8b80690833be,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-05_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-06_22-09.html,1667790540,2022-11-06,0,6ad6c3f26e31999264e1eefc8a2ce7f8,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-06_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-07_22-09.html,1667876940,2022-11-07,0,ea919cc1a93e2292a20b3cc6289c4178,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-07_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-08_22-08.html,1667963280,2022-11-08,0,2cdaf87199b507bec69433b748aa2033,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-08_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-09_22-08.html,1668049680,2022-11-09,0,26b79b00bf3bd607905f276e6ddd1686,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-09_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-10_22-10.html,1668136200,2022-11-10,0,b037cd154de975aae87d63d65542380e,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-10_22-10.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-11_22-08.html,1668222480,2022-11-11,0,29a25ca5c41cd2105d4dd4b3e05797c6,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-11_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-12_22-09.html,1668308940,2022-11-12,0,bf988a3471fcdb909e8716d2c2e9f54a,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-12_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-13_22-09.html,1668395340,2022-11-13,0,ed1c3aee9245992bf4320a2fe15834bf,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-13_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-14_22-09.html,1668481740,2022-11-14,0,90629801191020ddfec68842da0d5dfb,305105,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-14_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-15_22-08.html,1668568080,2022-11-15,0,97f7621afa610241af78fddb95f10078,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-15_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-16_22-09.html,1668654540,2022-11-16,0,14b3ed79f122e6139544ba2a81cba12a,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-16_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-17_22-08.html,1668740880,2022-11-17,0,edf433a108b9cc5a2d16986a5d22b481,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-17_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-18_22-09.html,1668827340,2022-11-18,0,f5c7dfb20e13ea04977dd426fbf0d5a4,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-18_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-19_22-09.html,1668913740,2022-11-19,0,cc608674deb222e27684dcd74d7fc473,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-19_22-09.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-20_22-08.html,1669000080,2022-11-20,0,116ff5874e07435bd940e7e326ccadf3,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-20_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-21_22-06.html,1669086360,2022-11-21,0,f399664fc54c4017a429bc551b2c7f70,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-21_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-22_22-08.html,1669172880,2022-11-22,0,9ddfefa9be4820e3109065ec7ab30a33,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-22_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-23_22-06.html,1669259160,2022-11-23,0,b419c7082458d2042bdf5983bb0a269b,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-23_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-24_22-06.html,1669345560,2022-11-24,0,9aeaa2022443aae0c33c7a79a7e4a8cc,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-24_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-25_22-06.html,1669431960,2022-11-25,0,f56fc0826efadc99a4fc4243f209c606,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-25_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-26_22-08.html,1669518480,2022-11-26,0,27bcb31625e32ae125ec598f1a5f7332,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-26_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-27_22-06.html,1669604760,2022-11-27,0,2454d40c74c0fb6c96561e9297fec1c7,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-27_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-28_22-06.html,1669691160,2022-11-28,0,4399b8718e59cac5824bd52674b5503c,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-28_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-29_22-06.html,1669777560,2022-11-29,0,b1dc2a07f0682f6920db2ad8c557af98,317156,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-29_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-30_22-07.html,1669864020,2022-11-30,0,3393c6a4dd5af6a7142e6ea17db6f674,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-11-30_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-01_22-07.html,1669950420,2022-12-01,0,72fb5d877986906744815eaa0d1401cf,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-01_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-02_22-07.html,1670036820,2022-12-02,0,f2111b58afa1f9b19757c52f32a455ed,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-02_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-03_22-07.html,1670123220,2022-12-03,0,93a2d8f62d113179b0408c17c92603a3,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-03_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-04_22-07.html,1670209620,2022-12-04,0,0193517da09412b8f2f297cbc578e7ba,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-04_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-05_22-06.html,1670295960,2022-12-05,0,b54b8752e0255d68a70bfb9f2900c890,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-05_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-06_22-06.html,1670382360,2022-12-06,0,9287c8fc9f00c1d57d73093870532511,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-06_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-07_22-06.html,1670468760,2022-12-07,0,38f67f943531722c6569844e17973c80,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-07_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-08_22-08.html,1670555280,2022-12-08,0,2d3e44fef2c01df06a3fb8f88b98eaf6,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-08_22-08.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-09_22-07.html,1670641620,2022-12-09,0,d68d516b66b34f9b840cd01fb05ee7e8,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-09_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-10_22-06.html,1670727960,2022-12-10,0,6b21dd16e686794c26e91cb8556ecf7c,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-10_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-11_22-07.html,1670814420,2022-12-11,0,99e8217db257260d7d6a083b582e7b65,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-11_22-07.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-12_22-06.html,1670900760,2022-12-12,0,8fd95123959d3b396ab9009f2ed674dd,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-12_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-13_22-06.html,1670987160,2022-12-13,0,92e3e72254be2c7c49ab030ec0fe3ef0,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-13_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-14_22-06.html,1671073560,2022-12-14,0,ddc3eff0cd90f645b29ff214fd3f328e,339994,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-14_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-15_22-06.html,1671159960,2022-12-15,0,8768dc2e407b8833b6662a6d780c71b3,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-15_22-06.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-16_22-16.html,1671246960,2022-12-16,0,81e7e29c2c2812b3539e35dd96a7d902,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-17_22-17.html,1671333420,2022-12-17,0,1db78fbe43dc3ab487adec8481f657ed,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-18_22-16.html,1671419760,2022-12-18,0,f08ced87d35934f96b8d3f0c60eaf884,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-19_22-17.html,1671506220,2022-12-19,0,ccce82051245f63ff8871cc51b18f983,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-20_22-17.html,1671592620,2022-12-20,0,20f7e7559c345f5ff7cb5f87998bd1bf,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-21_22-16.html,1671678960,2022-12-21,0,d833f2d2ad25fe163938f7049a6ee27d,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-22_22-16.html,1671765360,2022-12-22,0,379908c90eff38a83beb7cb8db490f82,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-23_22-16.html,1671851760,2022-12-23,0,672172bc6687bea58340c2c98f276511,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-24_22-17.html,1671938220,2022-12-24,0,f759cbad751c42df0174448ba7bc6b3e,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-24_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-25_22-16.html,1672024560,2022-12-25,0,3b99723756bc85abb453b2ae6a81121c,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-26_22-16.html,1672110960,2022-12-26,0,d78bd03d9a268dac2a0d99524dac28f8,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-26_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-27_22-16.html,1672197360,2022-12-27,0,07ae69584e6a509623eeacfff12ee3be,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-28_22-16.html,1672283760,2022-12-28,0,0fb9b3307b4646f6a9feb4d05c3d1480,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-29_22-16.html,1672370160,2022-12-29,0,91314ec5484eae4874b623d5841a9724,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-30_22-17.html,1672456620,2022-12-30,0,7c6bc3a48f7e800c057c64e0e9192d42,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-30_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-31_22-16.html,1672542960,2022-12-31,0,47f521694ea09b5cf06143b20a1af766,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2022-12-31_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-01_22-16.html,1672629360,2023-01-01,0,65766da854bb4d082009f02b88b5ee2a,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-02_22-17.html,1672715820,2023-01-02,0,dd77f838364910a312f0743238e6ea96,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-02_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-03_22-17.html,1672802220,2023-01-03,0,fac25aee2855ddae1e87d122c921376e,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-03_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-04_22-16.html,1672888560,2023-01-04,0,8b032966b13a0847fa978918be5b877a,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-05_22-17.html,1672975020,2023-01-05,0,1e7d8ba21d3478a3b0ce20d14d6d87e4,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-05_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-06_22-17.html,1673061420,2023-01-06,0,47dd919696d2e5c5640b006d9264f4bb,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-06_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-07_22-17.html,1673147820,2023-01-07,0,8d99bb74207ae713097d90a7ca63c71c,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-08_22-16.html,1673234160,2023-01-08,0,bd2be6915d9b8298453691920cb27d8b,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-09_22-17.html,1673320620,2023-01-09,0,cc0883d8e2c76427010016da2d207e28,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-10_22-17.html,1673407020,2023-01-10,0,fff48ffd0c379fef4ffb4f7d12c4e14d,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-10_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-11_22-17.html,1673493420,2023-01-11,0,fda7bb51d421a3cec14e038e547af7d2,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-11_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-12_22-16.html,1673579760,2023-01-12,0,d5be18a825b8c81d82193f1a34f1ecf7,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-13_22-17.html,1673666220,2023-01-13,0,bab46cea7a6c28ec8dab1ce6cfe2d20e,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-14_22-17.html,1673752620,2023-01-14,0,2c44b83a4393763b5d77c422339d8bfb,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-15_22-17.html,1673839020,2023-01-15,0,2b76aade9bea4b82625241ab05689d89,350866,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-15_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-16_22-17.html,1673925420,2023-01-16,0,40969f78daa31a34e8505f9380c87d3c,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-16_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-17_22-16.html,1674011760,2023-01-17,0,06dbfe6ad06fbbeca70b0a86534300c6,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-18_22-16.html,1674098160,2023-01-18,0,5510657a4f7abb3254bd7caa35da5443,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-19_22-17.html,1674184620,2023-01-19,0,68ed468453c3fa2f7eb2f8cf053dd4ac,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-20_22-16.html,1674270960,2023-01-20,0,179b419f9b32d964589a7633c7a9e359,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-20_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-21_22-16.html,1674357360,2023-01-21,0,82ec3f04401b9c63c05f226e27d1b966,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-22_22-16.html,1674443760,2023-01-22,0,6e75d1d77c67d057491c0e9290653efc,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-23_22-16.html,1674530160,2023-01-23,0,d1f962594f4bb72c279f6525ae4179bf,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-24_22-17.html,1674616620,2023-01-24,0,c233c5240826a7625a3adb439287b33d,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-24_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-25_22-16.html,1674702960,2023-01-25,0,f8e90433ce9196131d0fce5a41bcd532,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-26_22-17.html,1674789420,2023-01-26,0,83d25821d25473b83f345e01509222b7,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-27_22-16.html,1674875760,2023-01-27,0,c99350a31df7b41e19485820cb9e3688,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-28_22-16.html,1674962160,2023-01-28,0,8c1e7fce6c611c3eaf395b8d37fba270,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-29_22-16.html,1675048560,2023-01-29,0,4980a80a6902e98e033df0a9343939c0,390153,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-30_22-16.html,1675134960,2023-01-30,0,62ec8842cbe1e121c0a764247e988a26,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-30_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-31_22-17.html,1675221420,2023-01-31,0,87f91f99563f445f2173871c8100e871,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-01-31_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-01_22-16.html,1675307760,2023-02-01,0,a2004d0a34a095ca29d8bed1cc143aa7,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-02_22-16.html,1675394160,2023-02-02,0,c8dabd86f7d92e5afd42d56b7f1e1e18,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-03_22-17.html,1675480620,2023-02-03,0,2e69b7cd3261f65a45ef07c85c140ae1,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-03_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-04_22-17.html,1675567020,2023-02-04,0,8c243122ad6815ffe5aa68af972c8276,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-05_22-16.html,1675653360,2023-02-05,0,becb44ae908b06d68f3288e86dac280e,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-05_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-06_22-16.html,1675739760,2023-02-06,0,d80658fc4f6eb1d7a26eb1af082b1918,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-07_22-16.html,1675826160,2023-02-07,0,864f6c00ae12bb5147750f1d9ab1b3eb,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-07_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-08_22-17.html,1675912620,2023-02-08,0,5fb15dda0408264fa1f3ba6b7c2ec500,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-09_22-16.html,1675998960,2023-02-09,0,aea0462c416546fb083ac16e7bb7ea25,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-09_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-10_22-16.html,1676085360,2023-02-10,0,63a9fe4563b6573bc2c6945f0f48bfb8,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-10_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-11_22-16.html,1676171760,2023-02-11,0,b17229ebb343f0e810e279d1cf34513a,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-12_22-17.html,1676258220,2023-02-12,0,112be48138ee6aae33ca9d4b72c1515f,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-12_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-13_22-17.html,1676344620,2023-02-13,0,9681e08d703f89a315f94a0217d4aa89,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-14_22-17.html,1676431020,2023-02-14,0,ea0b3ce151334fb8ac6decb8c93fe088,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-15_22-16.html,1676517360,2023-02-15,0,df6ffab065e5721d03183c0dacc23e52,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-16_22-16.html,1676603760,2023-02-16,0,113440fd74d821cc780e7c5f959cade2,406299,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-17_22-16.html,1676690160,2023-02-17,0,349e9ace2eee25dc3e30b461f107965d,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-18_22-16.html,1676776560,2023-02-18,0,d788c007411641e80de36dbbd1776438,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-19_22-17.html,1676863020,2023-02-19,0,e9e2e52208d4a73f91c263aba13ca124,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-20_22-17.html,1676949420,2023-02-20,0,d0382917933458b296614a3995ed4255,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-21_22-20.html,1677036000,2023-02-21,0,b3f352389d80ba04f8ecc322048ae19e,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-21_22-20.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-22_22-16.html,1677122160,2023-02-22,0,b9c836b20374ea316844e98babd9b41f,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-23_22-54.html,1677210840,2023-02-23,0,08b3e7a4e2c2f1ebb13f7027c132a43d,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-23_22-54.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-24_22-17.html,1677295020,2023-02-24,0,1d0d5d9d2771c25c9097e5113dfcc1cb,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-24_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-25_22-16.html,1677381360,2023-02-25,0,64b4ea6eb61349c8a2e79aec10dcb4f9,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-26_22-17.html,1677467820,2023-02-26,0,158baf025e1ccb36330665998e097862,404500,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-27_22-16.html,1677554160,2023-02-27,0,ca030ab03d1e89640fe2cda0b8858c92,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-28_22-16.html,1677640560,2023-02-28,0,09b3f54264675a4b5958c494c54b2653,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-02-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-01_22-17.html,1677727020,2023-03-01,0,733ec32acf2c00a9d99fa7abd05b2141,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-01_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-02_22-16.html,1677813360,2023-03-02,0,f7954731a5361e38f31e8cbca57f7887,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-03_22-17.html,1677899820,2023-03-03,0,a10c3ebf2d3923b4bb46f871428aed52,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-03_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-04_22-16.html,1677986160,2023-03-04,0,9334f53f64be4d456b7a26d34746539b,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-05_22-16.html,1678072560,2023-03-05,0,8c843c0106537288f65d2baad0334ceb,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-05_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-06_22-17.html,1678159020,2023-03-06,0,7792097d19f893158a78be249d681e6f,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-06_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-07_22-17.html,1678245420,2023-03-07,0,7fe2406522f0e9f898c0f2d0cb5db9d1,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-08_22-17.html,1678331820,2023-03-08,0,4b990459f2779abd0349341a4331f380,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-09_22-17.html,1678418220,2023-03-09,0,dd74ea99b04314cf6d0c875923938067,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-10_22-16.html,1678504560,2023-03-10,0,25bba683822b13c5c915d7ea563e931d,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-10_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-11_22-16.html,1678590960,2023-03-11,0,29db66d7f750126e4ddeee2e69f7d719,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-12_22-16.html,1678673760,2023-03-12,0,8d905588bf9f899d8838c12b7a2ea7c9,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-13_22-17.html,1678760220,2023-03-13,0,4b40ac73528c227e312900670ac46425,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-14_22-17.html,1678846620,2023-03-14,0,5f459f2382ad425b0efcccf204e74c0d,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-15_22-17.html,1678933020,2023-03-15,0,52ed918fc8e4dc3697977394e793f774,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-15_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-16_22-17.html,1679019420,2023-03-16,0,a17f1cef9d84c41fdd1fe240d186aa0b,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-16_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-17_22-16.html,1679105760,2023-03-17,0,dbbcf8b2e6427d8b454b276c2ca5c1e8,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-18_22-16.html,1679192160,2023-03-18,0,31c3f91cc02428ec34aa0167942ec78d,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-19_22-16.html,1679278560,2023-03-19,0,8aaeb3f57f70020168929b9c35813b63,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-20_22-17.html,1679365020,2023-03-20,0,3d29398eb02f9a0f08784f01e5616784,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-21_22-17.html,1679451420,2023-03-21,0,a19b32b8e4f9548d31a72cccdc726c19,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-21_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-22_22-16.html,1679537760,2023-03-22,0,28f92b0b9df6e1da9b308df4a0837ec8,410151,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-23_22-16.html,1679624160,2023-03-23,0,ca36b0b50c2d2335a15912a927bada11,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-24_22-17.html,1679710620,2023-03-24,0,dd1a637f750621cc90666ef64549d204,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-24_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-25_22-16.html,1679796960,2023-03-25,0,abe8ad87f669369ef957095e377fa816,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-26_22-16.html,1679883360,2023-03-26,0,b9f2cea23938efca10d58296d2e77ffc,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-26_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-27_22-17.html,1679969820,2023-03-27,0,3f0f2c7fa2b5da37915549fbb42aa9ee,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-27_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-28_22-16.html,1680056160,2023-03-28,0,e89adfa0fb8ca45d0dbc14c9ae2cdbc2,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-29_22-16.html,1680142560,2023-03-29,0,5bb37bcb94408fcd2f3ca708c09f0873,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-30_22-17.html,1680229020,2023-03-30,0,5041c1e592141bc1d4f7ece7a7c4d32d,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-30_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-31_22-17.html,1680315420,2023-03-31,0,5f425aa43de7f335e6b2e510c77134c1,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-03-31_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-01_22-16.html,1680401760,2023-04-01,0,47db481b38537f286210476b828dab8c,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-02_22-16.html,1680488160,2023-04-02,0,d885aa443db1509ece7c18fdcb646b55,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-03_22-16.html,1680574560,2023-04-03,0,b6095d1356e9a147a34c5bdb00383312,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-03_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-04_22-16.html,1680660960,2023-04-04,0,b978a8f8da388f48a3af68d6473bf21a,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-05_22-16.html,1680747360,2023-04-05,0,f381d870fd80663daf645b4c55119260,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-05_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-06_22-16.html,1680833760,2023-04-06,0,7b10392ebac95c719a791bfa7ef20592,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-07_22-17.html,1680920220,2023-04-07,0,81076fb2ed19c8066406d4603a47e2b2,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-08_22-16.html,1681006560,2023-04-08,0,b0d03b8693fcab970bf69cec4beb0d62,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-09_22-17.html,1681093020,2023-04-09,0,27d9281534cd88fd18afa1230cd12569,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-10_22-17.html,1681179420,2023-04-10,0,7a4d2d26607907c60fe80064f4f4df37,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-10_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-11_22-17.html,1681265820,2023-04-11,0,877f012791211ded9332f39bff6b4625,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-11_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-12_22-16.html,1681352160,2023-04-12,0,3d415a975fd664cc98078e037a01693c,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-13_22-17.html,1681438620,2023-04-13,0,6e6c2be1d868d5691d91ad3af2f6b270,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-14_22-17.html,1681525020,2023-04-14,0,0e492e02fccdfe1e60a8cc9e7ee778b5,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-15_22-16.html,1681611360,2023-04-15,0,2e42fdc669479234a016e9e1b3ffd170,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-16_22-16.html,1681697760,2023-04-16,0,9d29cbb1a8a0975f10b51d3114aec5bb,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-17_22-17.html,1681784220,2023-04-17,0,c470e0dd89d922c2d1c357e964b99baa,395590,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-18_22-16.html,1681870560,2023-04-18,0,99c0d43ba0af73c5a793f54ced4ea266,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-19_22-17.html,1681957020,2023-04-19,0,73c213e606553c4cddde5f5c09579c6e,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-20_22-16.html,1682043360,2023-04-20,0,776ee4f7a9a77162672fc2fc071e784d,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-20_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-21_22-16.html,1682129760,2023-04-21,0,e0d46c94e1cf2c7db75277e2ba2135eb,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-22_22-17.html,1682216220,2023-04-22,0,d67f4a81455a32a3187187640abde376,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-22_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-23_22-17.html,1682302620,2023-04-23,0,509058bddbd9b79052a0c92ab67d7be9,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-23_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-24_22-17.html,1682389020,2023-04-24,0,75da301264f5d7d31338c901fd173309,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-24_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-25_22-16.html,1682475360,2023-04-25,0,a36143c68fb65f57bc61814148885a33,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-26_22-17.html,1682561820,2023-04-26,0,5d54bcf625aad2106072751a0b7cc03d,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-27_22-16.html,1682648160,2023-04-27,0,d4a05ed89b8aecf8abfb6f27c13c2743,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-28_22-16.html,1682734560,2023-04-28,0,1453c6006579b42fb2af47e33ff6554c,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-29_22-16.html,1682820960,2023-04-29,0,f893fc6d3dc04d1cda931228f8473e57,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-30_22-15.html,1682907300,2023-04-30,0,153be1710365132750360490b499deff,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-04-30_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-01_22-16.html,1682993760,2023-05-01,0,837a58f4a5a4cdb685ffe725eb144228,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-02_22-16.html,1683080160,2023-05-02,0,88e541ae4abc903c1170b6e0cf6e4075,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-03_22-20.html,1683166800,2023-05-03,0,3fa444a4dd82e0e4d020cddcb56ca224,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-03_22-20.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-04_22-17.html,1683253020,2023-05-04,0,b9f06ae58b621633b432bee8af333161,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-05_22-21.html,1683339660,2023-05-05,0,7d761c42f5ba3993512c4a3877a00910,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-05_22-21.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-06_22-17.html,1683425820,2023-05-06,0,f7b328cfc1c2ba54cc4acc1c3c236ac9,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-06_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-07_22-17.html,1683512220,2023-05-07,0,f56830f7e20edac2b25b66f86e44f8c6,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-08_22-17.html,1683598620,2023-05-08,0,dd643d28c61dbf1b32946be042ca53e4,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-09_22-20.html,1683685200,2023-05-09,0,053b19d1c042865432354faf24038368,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-09_22-20.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-10_22-18.html,1683771480,2023-05-10,0,26b32691c8737fb834c9ac8949f058dc,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-10_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-11_22-17.html,1683857820,2023-05-11,0,261368751015ec14f4afa83d30fa0bd4,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-11_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-12_22-17.html,1683944220,2023-05-12,0,1b6c0ca3eb85968218715fadb250dd2b,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-12_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-13_22-17.html,1684030620,2023-05-13,0,2948a738646f9e80b717e30312fcebc1,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-14_22-16.html,1684116960,2023-05-14,0,c7b0f21f3983004c9a9d0c8443b39235,416828,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-15_22-19.html,1684203540,2023-05-15,0,34e25ab170b1d791cd90bcf1983cd8c9,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-15_22-19.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-16_22-17.html,1684289820,2023-05-16,0,8c3c09bcde17f140c22f943ee9760db6,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-16_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-17_22-17.html,1684376220,2023-05-17,0,5f93626a3dd0d3bd14a0cc5eba944536,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-18_22-16.html,1684462560,2023-05-18,0,0ba08c7d4cce39d80bc31796807304d8,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-19_22-16.html,1684548960,2023-05-19,0,9d4374fc5a6f18f2482f5e71dd12e327,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-20_22-17.html,1684635420,2023-05-20,0,505e6af34f591b6397a61e16c63fa2dc,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-21_22-16.html,1684721760,2023-05-21,0,ef16150b14701b5c08888d0bcd69c9f3,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-22_22-16.html,1684808160,2023-05-22,0,20ce54482ef76f267a76750b96673aeb,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-23_22-17.html,1684894620,2023-05-23,0,935100c86a73aebb2d1bba2899832f85,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-23_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-24_22-16.html,1684980960,2023-05-24,0,2d104f172c3d70d91f109067ced75fb8,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-25_22-17.html,1685067420,2023-05-25,0,9837b571c8023591fa1eb8b802683aa8,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-25_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-26_22-17.html,1685153820,2023-05-26,0,bc4a83134bf826781fe5b0340c65ad43,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-27_22-18.html,1685240280,2023-05-27,0,656eeb38ede2619de1e44ed0d9e7b3cd,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-27_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-28_22-18.html,1685326680,2023-05-28,0,4dab995a2d70f076abbcad153caf77d9,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-28_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-29_22-15.html,1685412900,2023-05-29,0,b4cc9f9dae27c554f55397ab8939c91c,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-29_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-30_22-15.html,1685499300,2023-05-30,0,26d13735be47940fab3d386a8777ba9b,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-30_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-31_22-17.html,1685585820,2023-05-31,0,42f0a657784ae38b1e1f580d03674f50,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-05-31_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-01_22-16.html,1685672160,2023-06-01,0,c719dcd333005205a41f36ca4e143173,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-02_22-16.html,1685758560,2023-06-02,0,0d0b5a452cebe3a75c4ff29cc45cb612,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-03_22-16.html,1685844960,2023-06-03,0,b3096b92668a56859215a24318f2bfc4,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-03_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-04_22-16.html,1685931360,2023-06-04,0,7803ef27d50350a43cde5c6be2d7b092,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-05_22-16.html,1686017760,2023-06-05,0,0506e098e9e4bc4510930ebfffe649a0,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-05_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-06_22-17.html,1686104220,2023-06-06,0,bddc6f85e088d179ca1c4457ea0e74bb,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-06_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-07_22-16.html,1686190560,2023-06-07,0,2e870db326dd67443153b4679a99d5b9,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-07_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-08_22-17.html,1686277020,2023-06-08,0,ca638f2fee71046baab91e42d5f82494,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-09_22-17.html,1686363420,2023-06-09,0,edc640b41e9462143e94e2e2ba9f8fcb,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-10_22-17.html,1686449820,2023-06-10,0,1bdcdd5cada895de49be40f29fd70cbd,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-10_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-11_22-17.html,1686536220,2023-06-11,0,631b897bad26827f8e095fe7f3fbcf2a,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-11_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-12_22-17.html,1686622620,2023-06-12,0,02dd68eff25844f0bdc00b84f3b00319,489234,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-12_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-13_22-16.html,1686708960,2023-06-13,0,03e00ae40d941a0d0ca573e1fbb34904,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-14_22-16.html,1686795360,2023-06-14,0,2aa809fc7ee9c59232da9bed2b21e88e,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-15_22-17.html,1686881820,2023-06-15,0,c91fee6a12dd4e685db1470659a26d93,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-15_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-16_22-17.html,1686968220,2023-06-16,0,f4e477d07d697c437b3ac84503d15276,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-16_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-17_22-17.html,1687054620,2023-06-17,0,e13711db211de0eeffbb611ea0406d88,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-18_22-16.html,1687140960,2023-06-18,0,f8fd025bc671c25a5b4739d11a95ade2,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-19_22-16.html,1687227360,2023-06-19,0,e7d3bc112cd453a35be734c48ba0e033,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-20_22-16.html,1687313760,2023-06-20,0,b323ef866bc35f6fc7aa5d577fc1a8ae,186447,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-20_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-21_22-17.html,1687400220,2023-06-21,0,5ccaa160915b459d22b1f24160de8c96,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-21_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-22_22-16.html,1687486560,2023-06-22,0,4a03bb29e63adf2f9e561e85a338fb86,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-23_22-18.html,1687573080,2023-06-23,0,f719a168046b0175d73de1ea7c2b2839,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-23_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-24_22-16.html,1687659360,2023-06-24,0,946226fd0080791f7c56c893cf48d8ee,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-25_22-16.html,1687745760,2023-06-25,0,8b6ae19045a12d623bd168388c1f10a4,510782,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-26_22-17.html,1687832220,2023-06-26,0,b8831940f4c2aa8f47cfe6b6bd94a1b7,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-27_22-16.html,1687918560,2023-06-27,0,4754524d393e370ef6248637a2538d6e,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-28_22-17.html,1688005020,2023-06-28,0,f6e23cf0b7ee7b0b84959ab67fc25692,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-28_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-29_22-16.html,1688091360,2023-06-29,0,17644421fc4662cd40bf73de745bc38e,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-30_22-16.html,1688177760,2023-06-30,0,a927b52de28a486243c0590a3c3eb470,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-06-30_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-01_22-18.html,1688264280,2023-07-01,0,97ff957168bf6d49b6a6c242823fc3c2,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-01_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-02_22-16.html,1688350560,2023-07-02,0,8a7aefa76e7a6381dcd64739c4583596,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-03_22-18.html,1688437080,2023-07-03,0,01ae8b452d85b017c9a4bef37a22a47f,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-03_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-04_22-16.html,1688523360,2023-07-04,0,39811398f624fa30b560c50c94c5af4d,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-05_22-17.html,1688609820,2023-07-05,0,11b97a4bcd6f6409f555ccde7ca83eec,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-05_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-06_22-17.html,1688696220,2023-07-06,0,4d04a33ed68e04d49b49eeb2eee99ad8,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-06_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-07_22-17.html,1688782620,2023-07-07,0,53e13bf118a24cb43faaf327fc9123ae,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-08_22-17.html,1688869020,2023-07-08,0,e8bf8e1d5fe4d481e0073de8b3a2b906,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-09_22-17.html,1688955420,2023-07-09,0,03ac97a42a6c3c920b3e41050cfa51e3,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-10_22-17.html,1689041820,2023-07-10,0,4a90a6d67167a4044c2361305ffc7708,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-10_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-11_22-16.html,1689128160,2023-07-11,0,63f59345a873bd53838d160e0a2c5e1d,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-12_22-16.html,1689214560,2023-07-12,0,7c2924c030dd15667f84fe31015719e4,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-13_22-17.html,1689301020,2023-07-13,0,562fdc5bc72aa4717cb270c075f47d5e,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-14_22-16.html,1689387360,2023-07-14,0,e5cbe799fdfc4e533d44fed9fd2bd0a0,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-15_22-16.html,1689473760,2023-07-15,0,71c967fe9ed6a9d6329a544d07f92bf9,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-16_22-16.html,1689560160,2023-07-16,0,d14b56bec40a02cde0202f6c972554ac,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-17_22-17.html,1689646620,2023-07-17,0,5d9292d503648c122b8584a2888a9730,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-18_22-17.html,1689733020,2023-07-18,0,3de802c3982a56695662e94ed9773b84,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-18_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-19_22-17.html,1689819420,2023-07-19,0,e2ffc330bbd35ec75397f65993fecb8a,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-20_22-17.html,1689905820,2023-07-20,0,402f1d0e92bcf358e0f9df2bad0dbeb6,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-21_22-17.html,1689992220,2023-07-21,0,274273383a640616323988d32520e817,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-21_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-22_22-17.html,1690078620,2023-07-22,0,a118817290cab9cf4585c61b809d3009,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-22_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-23_22-16.html,1690164960,2023-07-23,0,3dc3df9833d0f5ed97f623d1312fe23d,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-24_22-16.html,1690251360,2023-07-24,0,ab1006bfa7012ddbeec1ab92d4f21b4a,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-25_22-17.html,1690337820,2023-07-25,0,5d1e0b7d40a76ef1ecceecbf89e39b1b,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-25_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-26_22-17.html,1690424220,2023-07-26,0,1dff21ac164c0a11dbb1a5c542f70877,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-27_22-19.html,1690510740,2023-07-27,0,112355dac6a7a58ab60deea7e679ab33,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-27_22-19.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-28_22-17.html,1690597020,2023-07-28,0,99829cac9d523e67b374ba3dfb329b83,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-28_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-29_22-17.html,1690683420,2023-07-29,0,e2be39d9192c03d8ffa3f6569970604e,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-29_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-30_22-17.html,1690769820,2023-07-30,0,aab026f7c126d7c026f0313f45120890,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-30_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-31_22-17.html,1690856220,2023-07-31,0,534a3f31f117778a856a9f19185e6b09,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-07-31_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-01_22-16.html,1690942560,2023-08-01,0,29c26750b61e9654ba83abedfd7a9cab,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-02_22-17.html,1691029020,2023-08-02,0,b7f82658962ccb4560db2328c8fb79e3,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-02_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-03_22-17.html,1691115420,2023-08-03,0,6ef6695fd676fae8c00e4e2b774f9fb3,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-03_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-04_22-17.html,1691201820,2023-08-04,0,2a71b964e121d5c7af4a1f960f4f20e6,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-05_22-16.html,1691288160,2023-08-05,0,2f39f63647fdd7296e28e38d953afe6c,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-05_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-06_22-18.html,1691374680,2023-08-06,0,b9c179106cd556acfd10f4f6300c7012,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-06_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-07_22-18.html,1691461080,2023-08-07,0,523afdc13173078c6ebb620f77de228b,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-07_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-08_22-17.html,1691547420,2023-08-08,0,f5e3c6625cbc69d8a639c3ab8c785a8e,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-08_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-09_22-17.html,1691633820,2023-08-09,0,d28bdabeea0ec3c147adf239ff055cf4,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-10_22-16.html,1691720160,2023-08-10,0,cb3a9d35b4ddecb3167eae8fa390152d,542966,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-10_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-11_22-16.html,1691806560,2023-08-11,0,68eccf2490884faf4ebbd9147e2f4818,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-12_22-16.html,1691892960,2023-08-12,0,31abc6d72c29612c79c129a799f54d75,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-13_22-17.html,1691979420,2023-08-13,0,4ea04296c29213f56074395516c6c1a8,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-13_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-14_22-17.html,1692065820,2023-08-14,0,952ae58a909da13ce81366f520f57503,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-15_22-17.html,1692152220,2023-08-15,0,c64b967e77ee297a1a95f4dfbc30628e,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-15_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-16_23-59.html,1692244740,2023-08-16,0,30a5e31867b0db8fc940ba0163f59c1f,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-16_23-59.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-17_22-20.html,1692325200,2023-08-17,0,375e4752c9271df75546baf43223706a,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-17_22-20.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-18_22-17.html,1692411420,2023-08-18,0,a8e3df8cb2cae5866d079f280bf91aa7,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-18_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-19_22-17.html,1692497820,2023-08-19,0,7f1c5f1a3e9236a6a6ca50bc6a82bd72,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-20_22-17.html,1692584220,2023-08-20,0,be88f1e21bccf9046b81c6136f212d64,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-20_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-21_22-17.html,1692670620,2023-08-21,0,b4ebc1b21388e3e27ed0ceb924b5d0cc,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-21_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-22_22-17.html,1692757020,2023-08-22,0,61b5d8f672d5d6a54e96967d86150e92,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-22_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-23_22-16.html,1692843360,2023-08-23,0,a69ebc5336732909ac05091ceed1eea7,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-24_22-16.html,1692929760,2023-08-24,0,890487809f747ed5be016ec213b93130,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-25_22-17.html,1693016220,2023-08-25,0,a3a68689cb1f9ddcc57e1fefe1c1e2f0,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-25_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-26_22-16.html,1693102560,2023-08-26,0,bd63b8cfe890e5ee19cb5cadf4d2bcbb,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-26_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-27_22-17.html,1693189020,2023-08-27,0,9c66944680101d6dd253d816c550b7f8,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-27_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-28_22-23.html,1693275780,2023-08-28,0,a88502003038d552c2faf9a6d40232e1,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-28_22-23.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-29_22-16.html,1693361760,2023-08-29,0,5a0f89d9cd27262bda2179a7732a7b86,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-30_22-16.html,1693448160,2023-08-30,0,dbca25632a928b60f23ebf71c91c5457,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-30_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-31_22-15.html,1693534500,2023-08-31,0,b86f504c630badbbbb369eb3e35fa24c,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-08-31_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-01_22-16.html,1693620960,2023-09-01,0,d9718037f946c06daf6d27920cb83080,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-02_22-16.html,1693707360,2023-09-02,0,9be85772d2b88d2dce195ec8205c470f,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-03_22-15.html,1693793700,2023-09-03,0,d04eba5992d37525f51211eaccbe7de4,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-03_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-04_22-16.html,1693880160,2023-09-04,0,1ef77435dede093d8a65c375fad06777,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-05_22-17.html,1693966620,2023-09-05,0,984a8c30ef63a2226aaddb4562bc53c5,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-05_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-06_22-16.html,1694052960,2023-09-06,0,c74405e2cae5da762c47ba35bcdd23cc,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-07_22-15.html,1694139300,2023-09-07,0,cad5352cd895af554a6550d216b2c743,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-07_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-08_22-16.html,1694225760,2023-09-08,0,878b4cdecbeb7225ae309de2a8ee774d,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-09_22-20.html,1694312400,2023-09-09,0,25afdaf8939a604e10bc4804b42524b7,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-09_22-20.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-10_22-18.html,1694398680,2023-09-10,0,857837a38aad8e04bb322aa3b1439bd3,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-10_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-11_22-16.html,1694484960,2023-09-11,0,2fa114d72f04d6770e6f6caba5a4359e,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-12_22-17.html,1694571420,2023-09-12,0,8ed9a6917412f6331169fe3f89dfe383,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-12_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-13_22-16.html,1694657760,2023-09-13,0,6e5c50cfd16e835471e0476d8cbc7adf,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-14_22-37.html,1694745420,2023-09-14,0,d68639e1e3c78f31fc77c3579780e1c8,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-14_22-37.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-15_22-16.html,1694830560,2023-09-15,0,7437128100cceac36585aa0d000f0d5d,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-16_22-16.html,1694916960,2023-09-16,0,d3eef271c8fc03b80eb36b58f0522ccd,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-17_22-16.html,1695003360,2023-09-17,0,0058f39cc7b723964f4c4d31ecb7efc9,576541,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-18_22-16.html,1695089760,2023-09-18,0,e4e8274a68285aa1c4831e18278280a4,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-19_22-16.html,1695176160,2023-09-19,0,c39c43cefd8a2e5385a6a12c1989947e,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-20_22-16.html,1695262560,2023-09-20,0,1f85e8039a98a54ef42d66bf03605ddf,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-20_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-21_22-16.html,1695348960,2023-09-21,0,ca47ea25879209e3618ce3171a9169bf,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-22_22-17.html,1695435420,2023-09-22,0,d33712dbc652c9c7062d4f66777f082d,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-22_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-23_22-16.html,1695521760,2023-09-23,0,f077b9601f85a001b3046add4495ca34,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-24_22-16.html,1695608160,2023-09-24,0,8dc74a5bdfeb7a3c95537dcf4bcb1711,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-25_22-16.html,1695694560,2023-09-25,0,75aed6a0363d125cbdbfbf5eede4e6e2,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-26_22-17.html,1695781020,2023-09-26,0,d76325d3f02328f84d159bc364e261ac,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-26_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-27_22-16.html,1695867360,2023-09-27,0,4fc807f3cf3f2604bbe45fb3745cddfc,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-28_22-16.html,1695953760,2023-09-28,0,0a0cfffa4ca58800f71fe0767e7f3ae8,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-29_22-16.html,1696040160,2023-09-29,0,c2c0d5d72c4f6413b90d637ca369789e,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-30_22-17.html,1696126620,2023-09-30,0,3d643febbfab5a4ee7a52adb21ffd34a,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-09-30_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-01_22-15.html,1696212900,2023-10-01,0,41e38d06d979dd6bf3776fedc6d8c660,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-01_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-02_22-16.html,1696299360,2023-10-02,0,95054ee9d274b7c2adb91d875b9f78fb,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-03_22-16.html,1696385760,2023-10-03,0,bcbf6aa76fb9d1cb076da8c7a50525f7,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-03_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-04_22-17.html,1696472220,2023-10-04,0,0315c391521cb7088159cb7023de7564,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-05_22-17.html,1696558620,2023-10-05,0,b8014b5783ab62b5bdcce064e6adde8f,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-05_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-06_22-16.html,1696644960,2023-10-06,0,054d944c88652ec7f99833c6fe2f50c4,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-07_22-15.html,1696731300,2023-10-07,0,1cc7b537fecb29826f62c48f28482a18,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-07_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-08_22-16.html,1696817760,2023-10-08,0,a81da2cb53e38a48cdcaf680a0912b39,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-09_22-17.html,1696904220,2023-10-09,0,dedce7e658c00849377ab21169baf44b,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-09_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-10_22-17.html,1696990620,2023-10-10,0,5df440964aa6323312045ee5b0fd98af,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-10_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-11_22-18.html,1697077080,2023-10-11,0,bfd0bf245e9df0b38b53051d536712b8,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-11_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-12_22-16.html,1697163360,2023-10-12,0,47ae0fb2ab51b340c50177613cd02400,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-13_22-16.html,1697249760,2023-10-13,0,394bff1cc385ff3315fda42cd6c0a2de,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-14_22-17.html,1697336220,2023-10-14,0,642d652212853bc49dcb1fcd1b4929de,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-14_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-15_22-16.html,1697422560,2023-10-15,0,5f607be923ed965e1d6a48279e8ac798,619509,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-16_22-17.html,1697509020,2023-10-16,0,c9c20af1bcb107594b8483f85b1fdde8,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-16_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-17_22-16.html,1697595360,2023-10-17,0,e30bcab48166d0b207e6af0caea97461,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-18_22-16.html,1697681760,2023-10-18,0,d041dd97e259dfcbff06631f52ed1534,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-19_22-17.html,1697768220,2023-10-19,0,14178a39af6051716693501f6ad74f71,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-19_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-20_22-16.html,1697854560,2023-10-20,0,d9d89533a0ceea4354b90bddb7817e26,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-20_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-21_22-15.html,1697940900,2023-10-21,0,90bd48d0a5d377b8e6ef8582b4f9f5ec,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-21_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-22_22-17.html,1698027420,2023-10-22,0,49226a74542f9e0586ab75e247e7f49d,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-22_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-23_22-16.html,1698113760,2023-10-23,0,62f708b79c1c76d4469ffba57b08015c,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-24_22-16.html,1698200160,2023-10-24,0,f9e8f2516979cf9df8a63eb7b13897eb,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-25_22-16.html,1698286560,2023-10-25,0,bbee60cb38e81a49edadb49438d51b07,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-26_22-16.html,1698372960,2023-10-26,0,932b5d7cefbdd99c24134bec6dec3757,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-26_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-27_22-16.html,1698459360,2023-10-27,0,03131eed95d92a844a5402e6a0d16ce5,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-28_22-16.html,1698545760,2023-10-28,0,36228fd854ecba8891aaf59483d932c3,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-29_22-17.html,1698632220,2023-10-29,0,06efb7fd69bdc613b980a628c0ed07eb,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-29_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-30_22-16.html,1698718560,2023-10-30,0,b4f67838f11a3075916bcf7d7e042fcf,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-30_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-31_22-17.html,1698805020,2023-10-31,0,73ad1640ba6123114f0d24caf181231d,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-10-31_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-01_22-17.html,1698891420,2023-11-01,0,49f85cb3395292e6d7e73ae834529c57,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-01_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-02_22-16.html,1698977760,2023-11-02,0,2bb901dec2f281965a1810ea52c0a6aa,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-03_22-18.html,1699064280,2023-11-03,0,bb67c18608f59eb96e5687ffdf3c69ac,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-03_22-18.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-04_22-17.html,1699150620,2023-11-04,0,5b123d7e8512a338df47fadd2c1b2f59,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-05_22-17.html,1699240620,2023-11-05,0,fdc152dd42cdc39930578c64d2d4d5cb,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-05_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-06_22-16.html,1699326960,2023-11-06,0,f97533fab7fe916fc3d253b2144c9324,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-07_22-16.html,1699413360,2023-11-07,0,ed0bcd042cbd20a3ffe12731a397584e,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-07_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-08_22-16.html,1699499760,2023-11-08,0,693826ba549466a4c4219560a0aef915,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-09_22-16.html,1699586160,2023-11-09,0,d80bc6f47bdb92a30d574644d9b585bc,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-09_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-10_22-15.html,1699672500,2023-11-10,0,a719f1f5df831b49343c06e12535a6c0,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-10_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-11_22-17.html,1699759020,2023-11-11,0,c23f9dfe9e62d09d75a7a90c8b442a93,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-11_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-12_22-17.html,1699845420,2023-11-12,0,2ef4377bbdf5f2bf667ae75f7d10a02e,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-12_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-13_22-16.html,1699931760,2023-11-13,0,81c37c9751cc4f2e0fa3b0fc5763a3b3,596592,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-14_22-16.html,1700018160,2023-11-14,0,1ba2319b53fef3885898d644e4e0b12c,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-15_22-16.html,1700104560,2023-11-15,0,e3931daa259473d4bb61480f56756cd8,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-16_22-16.html,1700190960,2023-11-16,0,4b3abc44ad749ec94ae528b158095c67,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-17_22-17.html,1700277420,2023-11-17,0,42155276c39a35fb999c2da5cd1f4a8d,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-17_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-18_22-16.html,1700363760,2023-11-18,0,b42df0c0925b36e6be5ea88ec92d07c7,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-18_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-19_22-15.html,1700450100,2023-11-19,0,5129c4d6397d67e9505bee3a3fbdec98,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-19_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-20_22-15.html,1700536500,2023-11-20,0,5d61b542b41d24f194476ce6081e3740,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-20_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-21_22-16.html,1700622960,2023-11-21,0,a7b04001fda1a7fa821d9a61e685b78e,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-21_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-22_22-16.html,1700709360,2023-11-22,0,483896c5814105272dc7631e6d03acd4,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-23_22-16.html,1700795760,2023-11-23,0,c4a55b1c15732079a4917ce12bd9e06f,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-24_22-26.html,1700882760,2023-11-24,0,5cf5bf3352256e2565fd76b6c9ce28c6,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-24_22-26.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-25_22-15.html,1700968500,2023-11-25,0,b1098cd4f11c6891dcbbb8715a3c08a8,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-25_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-26_23-59.html,1701061140,2023-11-26,0,2b061a4192cb4944bc5b691f035168f6,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-26_23-59.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-27_22-16.html,1701141360,2023-11-27,0,e3c7e966897f725d8db01b2910e26971,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-27_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-28_22-16.html,1701227760,2023-11-28,0,53d4f40cb31297dd8a43eba9691565ef,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-29_22-17.html,1701314220,2023-11-29,0,77b0b53dbc7ceb85343baad072934ceb,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-29_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-30_22-15.html,1701400500,2023-11-30,0,aefcf7dccc62c04f64b7d7e3321c4861,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-11-30_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-01_22-15.html,1701486900,2023-12-01,0,0902b6b1f5d9095d0b2680c4fb93766e,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-01_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-02_22-16.html,1701573360,2023-12-02,0,966cfbb83db4c11b8e1d23c07798b991,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-02_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-03_22-16.html,1701659760,2023-12-03,0,6f48cbe9e418c3581ee9c830a31b84c6,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-03_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-04_22-16.html,1701746160,2023-12-04,0,2a87f61ecea8101089e48f4ccec1551e,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-04_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-05_22-15.html,1701832500,2023-12-05,0,69bb6404a750b9d97f2611b70ea70b1b,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-05_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-06_22-16.html,1701918960,2023-12-06,0,d4665a1900a578539090a34647d4447e,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-06_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-07_22-15.html,1702005300,2023-12-07,0,fd509e249f18283e52c87d44eec39009,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-07_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-08_22-16.html,1702091760,2023-12-08,0,dd8240ddba05ce02e86820579c872cdc,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-08_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-09_22-15.html,1702178100,2023-12-09,0,8ea6769b257843abd1d3835f758952a4,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-09_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-10_22-16.html,1702264560,2023-12-10,0,3f196a964ffae15eedd253f45f2656fd,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-10_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-11_22-16.html,1702350960,2023-12-11,0,683d2a20649cc28c9cc8d431a12f0cfa,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-12_22-16.html,1702437360,2023-12-12,0,d8a2265538161e64c0d6139dea148bf2,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-13_22-16.html,1702523760,2023-12-13,0,be835bc8f1342111f7a4ca620e07aa8c,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-14_22-16.html,1702610160,2023-12-14,0,882247f265ac1dd645b2dc1c1124d8df,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-15_22-16.html,1702696560,2023-12-15,0,f26a404363ba49a29317161c3622a5f4,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-15_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-16_22-15.html,1702782900,2023-12-16,0,8de408439a6d87306834f6c7cf128eb2,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-16_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-17_22-15.html,1702869300,2023-12-17,0,17143cc156cd8775509f23935277ccc2,670792,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-17_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-18_22-15.html,1702955700,2023-12-18,0,c1b43d7c4efe95f4c17ce3ed2fc3f223,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-18_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-19_22-16.html,1703042160,2023-12-19,0,c1a3cc5f7a778f82facfb59500683441,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-20_22-15.html,1703128500,2023-12-20,0,0e96b5d95fe6795afdd5c6ecceb5b4e8,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-20_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-21_22-15.html,1703214900,2023-12-21,0,67ec4a61434c7a385f5a2075c55c6341,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-21_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-22_22-15.html,1703301300,2023-12-22,0,e93951161ca8491ef38072104c749bc6,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-22_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-23_22-15.html,1703387700,2023-12-23,0,e22c11740fc1fd3cfd6957dfe1d70efd,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-23_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-24_22-15.html,1703474100,2023-12-24,0,60113195599a4197fcfc1bd98b079583,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-24_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-25_22-16.html,1703560560,2023-12-25,0,7b82261b8e58813eafd43228ae2fbc87,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-26_22-15.html,1703646900,2023-12-26,0,b0e0b49932a0a299a8a3be5ab9d5f645,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-26_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-27_22-15.html,1703733300,2023-12-27,0,3fc9cbe9c1d28f1843a754c1e80f0d33,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-27_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-28_22-15.html,1703819700,2023-12-28,0,d12147735484e6fc12adae84493e78bd,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-28_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-29_22-16.html,1703906160,2023-12-29,0,f1dda19ba21d452ce444c6064c3fd749,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-30_22-17.html,1703992620,2023-12-30,0,8c17ce6e79d643d390a29baa831317a5,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-30_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-31_22-16.html,1704078960,2023-12-31,0,24951544c925ad29d0a55bbed119716a,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2023-12-31_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-01_22-16.html,1704165360,2024-01-01,0,ff767a94b619f312e519105f14123e61,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-01_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-02_22-15.html,1704251700,2024-01-02,0,91132a21f1cb9498a9886c33d531731d,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-02_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-03_22-15.html,1704338100,2024-01-03,0,360476215648534b49bf1d6a56eada22,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-03_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-04_22-17.html,1704424620,2024-01-04,0,166f5540f068f4434bb883a75c904a9d,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-04_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-05_22-15.html,1704510900,2024-01-05,0,f8e14fe755c4dfbb8ad5d76f0698045e,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-05_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-06_22-15.html,1704597300,2024-01-06,0,71a61be2806577467abb8978f435b7c2,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-06_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-07_22-17.html,1704683820,2024-01-07,0,0d951bcbb07e0fdaa86df3b6d69db9d6,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-07_22-17.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-08_22-15.html,1704770100,2024-01-08,0,7b7d1fe89698d9671010599aa2ab2439,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-08_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-09_22-15.html,1704856500,2024-01-09,0,75e68a54f5cfccd8092101737b4ff0df,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-09_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-10_22-16.html,1704942960,2024-01-10,0,dcf1a256867b7a614fa8f25fde23ac82,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-10_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-11_22-16.html,1705029360,2024-01-11,0,95b2cbcfc4926847c607dd26902924be,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-11_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-12_22-16.html,1705115760,2024-01-12,0,324078fc878bd9adf6c56ebf98c865e4,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-12_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-13_22-16.html,1705202160,2024-01-13,0,7fcd20ec312c3bf7a57525d85cfaa275,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-13_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-14_22-16.html,1705288560,2024-01-14,0,b06c788102c2b6bb6295712ce7dfed4f,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-14_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-15_22-15.html,1705374900,2024-01-15,0,f3aec058cf19e197641d21a3f201dd88,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-15_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-16_22-16.html,1705461360,2024-01-16,0,d59cf1e4b40ac7b6efd7643b52e91a8f,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-16_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-17_22-16.html,1705547760,2024-01-17,0,88fdffacbd23ce17f6dbd7ccece3665e,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-17_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-18_22-15.html,1705634100,2024-01-18,0,36a38a82987903689e5efe408abe23d5,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-18_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-19_22-16.html,1705720560,2024-01-19,0,4529a027432dcce938be8a88c10f22df,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-19_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-20_22-15.html,1705806900,2024-01-20,0,ee5d476e871fe1e622b597d6bf99703f,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-20_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-21_22-15.html,1705893300,2024-01-21,0,95431517985fc2de7a7718be43b4bdf4,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-21_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-22_22-16.html,1705979760,2024-01-22,0,862a1345bd725a6ac15a26e4f1911ec1,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-22_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-23_22-16.html,1706066160,2024-01-23,0,21220e59f62397f5ffb5187da8ff279e,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-23_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-24_22-16.html,1706152560,2024-01-24,0,0cf4aff57658876c4d3d40e0995cbe6c,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-24_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-25_22-16.html,1706238960,2024-01-25,0,c37e3da7dde2812004ee3390bd1d887c,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-25_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-26_22-16.html,1706325360,2024-01-26,0,3fac0c2d7edeed00aa95eb1a15c1a5ed,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-26_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-27_22-15.html,1706411700,2024-01-27,0,fd54054bb4029b6b06ebbfe43e4e9ee6,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-27_22-15.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-28_22-16.html,1706498160,2024-01-28,0,2a2b16bbaceb7b6d5004fd24a0786d9b,688962,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-28_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-29_22-16.html,1706584560,2024-01-29,0,6a916e31818877e546fdecf712bc916e,706612,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-29_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-30_22-16.html,1706670960,2024-01-30,0,24924d5fea0430dda92311dca0604702,706612,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-30_22-16.html
6c4c0945-babe-48f4-a656-992cf815b8c5,citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-31_22-17.html,1706757420,2024-01-31,0,b6ea27e39f43f260cde8ae92ca9774d6,706612,https://archive.org/download/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5/cc19da_6c4c0945-babe-48f4-a656-992cf815b8c5.zip/citf-seroprevalence-in-canada-sars-cov-2-antibody-seroprevalence-in-canadian-blood-donors-over-time-canada-excluding-quebec-and-the-territories-webpage_2024-01-31_22-17.html
